ATYR

aTYR PHARMA INC

Biological Products, (No Diagnostic Substances)NasdaqNon-accelerated filer<br>Smaller reporting company

Total Trades

8

Buys

2

Sells

3

Largest Trade

N/A

Insiders

4

Institutional Funds

62

Inst. Value

$1M+

Insider Trades

InsiderTitleTypeValueSharesPriceDate
Shukla SanjayPresident and CEOEXERCISEN/A10KFeb 5, 2026
Shukla SanjayPresident and CEOSELL$1K–$15K4K$0.98Feb 5, 2026
Broadfoot Jill MarieCFOEXERCISEN/A4KFeb 5, 2026
Broadfoot Jill MarieCFOSELL$1K–$15K2K$0.98Feb 5, 2026
DENYES NANCYGeneral CounselSELL$1K–$15K1K$0.98Feb 5, 2026
DENYES NANCYGeneral CounselEXERCISEN/A3KFeb 5, 2026
Gross Jane ADirectorBUY$15K–$50K4K$4.00Mar 17, 2025
DENYES NANCYGeneral CounselBUY$1K–$15K5K$1.86Jun 6, 2024
🔓Seeing ranges? Sign in for exact trade values — free forever

Institutional Ownership

13F filings as of Dec 31, 2025 · 62 funds holding

FundShares
Rosalind Advisors, Inc.1.0M
FEDERATED HERMES, INC.10.5M
GSA CAPITAL PARTNERS LLP2.6M
GEODE CAPITAL MANAGEMENT, LLC2.0M
STATE STREET CORP1.7M
UBS Group AG1.5M
VANGUARD GROUP INC649K
Tikvah Management LLC461K
CHARLES SCHWAB INVESTMENT MANAGEMENT INC222K
GROUP ONE TRADING LLC191K
VICTORY CAPITAL MANAGEMENT INC182K
JANE STREET GROUP, LLC178K
BARCLAYS PLC174K
WELLS FARGO & COMPANY/MN104K
RHUMBLINE ADVISERS100K
GOLDMAN SACHS GROUP INC86K
Virtu Financial LLC79K
JPMORGAN CHASE & CO69K
ALLIANCEBERNSTEIN L.P.64K
Bank of New York Mellon Corp56K
View on Google Finance →